Catalent
Manufacturing · Florida, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
41st Floor Bank of America Plaza 101 E K...Phone Number
(877) 587-1835Website
www.catalent.comRevenue
$4.4 BillionStock Symbol
CTLTIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
14
18
1
3
2
2
About Catalent
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.Explore more
Catalent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Catalent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Catalent, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Catalent had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Catalent recently announced quarterly report
Funding: Get notified immidiatlly once Catalent has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Catalent launches new products
Congratulate Masked Content for being promoted to Masked Content at Catalent
Check out if Catalent is spiking on competitors!
Check if Catalent has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Catalent as Masked Content
Find more new buyers
Compare Similar Companies to Catalent
Compare insights from companies similar to Catalent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Catalent
$4.4B
10K+
Public
$5.2B
2007
CH
Christopher HajjarVice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer
$3.8B
10K+
Private
-
1983
AF
Amy FranceSenior Vice President, Chief Financial Officer - Consulting and Commercial
Company Profile Activity
Activity Insights
Catalent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Catalent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Catalent.
Catalent financials insights
Gather financial insights about Catalent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$870M
2016
Debt
$410.1M
2017
Stock Offering
$24.2M
Debt
$450M
2018
Stock Offering
$387M
2019
Debt
$1.2B
Debt
$500M
2020
Stock Offering
$500M
Debt
$903.4M
Catalent Tech Stack
A closer look at the technologies used by Catalent
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Pharmaceuticals
Open Position
Catalent News & Media
Incyte's Lung Cancer Expansion Bid Thwarted by Issues at Novo's Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.Another Round of Catalent Layoffs Hits Maryland — Over 500 Workers Impacted in the Past Year
Catalent has been hit by another round of workforce reductions at its Maryland operations, marking the latest chapter in an ongoing contraction affecting the state’s gene therapy manufacturing footprint. According to a Maryland WARN filing, the company plans to eliminate 96 positions across its Harmans gene therapy campus and Baltimore operations, with the layoffs taking…Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
The global pharma giant laid off more than 400 employees in the state last year.Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Catalent
Sign Up For FreeTo access detailed company insights
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development... Read More
